Chair and Scribe: Floyd Eisenberg 

Minutes from last call: OMOP Quality Measurement 9 March 2022

Recording of this call (access requires passcode):

Next FHIR-OMOP All Hands Meeting - March 28, 2022 (Monday) 4-5 PM ET - Subgroup leads will provide updates on their progress and 2022 roadmap (primary goals, objectives and deliverables).  You can find login details below.

The FHIR-OMOP WG- subgroups are as follows:

    • Data Model Harmonization 
    • Data Quality Measurements 
    • Terminologies 
    • Oncology 

Zoom Meeting: https://us02web.zoom.us/j/83645856405?pwd=OHJRdVVtb3BBQTdVaWp5UlBXUEdvUT09


Agenda TopicDiscussion Notes
New Discussion Topics/Updates:

Demo: Jack Brewster from IQVIA quick demo to show how to import VSAC into Atlas automatically using R packages. 

Jack Brewster provided a demonstration of work to automate the import of VSAC value sets starting with a CSV file and using R packages, process all eCQM value set packages in under 1 hour without any performance issues on the Atlas production environment. This capability is a significant improvement on prior demonstrations of manual mapping to the OMOP concept codes. There were only 2 value set concepts that did not map, the hospital location codes (ICU), for which there is no corresponding concept in OMOP. There were no ambiguous mappings since all involve specific terminology code (SNOMED, LOINC, ICD, CPT, etc.) to OMOP concept codes. The process did not use the VSAC FHIR API but it could be considered as part of the methodology; this effort started with the CSV output from VSAC. A number of participants indicated interest in the code for reuse, and Jack Brewster agreed to make it available for others to use.

Refer to the recording of the discussion for specific details.  Some specific points in the discussion:

  • Gravity HL7 Accelerator value sets are part of the Social Determinants of Health (SDOH) content referenced by the US Clinical Data for Interoperability (USCDI) version 2 that is now being incorporated into US FHIR Core. Davera Gabriel indicated some effort to work with these value sets and that they are not yet incorporated into OMOP. She referenced Jake Gillberg (gillberg@ohdsi.org) as the lead of the OHDSI Health Equity Working Group for such efforts.
  • The group had some discussion about licensing permission for use of terminologies in the VSAC requires an NLM license to access any content. Kristin Kostka noted some work to address licensing, especially around SNOMED already exists in OHDSI and may be applied. 

See the recording (referenced at the top of this page) for the detailed conversation and the demonstration.


Review of proposed Oncology FHIR-to-OMOP process for May Connectathon to provide context (2022-05 FHIR-OMOP Oncology)

Floyd showed the workflow proposed for the May FHIR Connectathon from the FHIR-OMOP Oncology group (2022-05 FHIR-OMOP Oncology). The flow from left-to-right starts with a provider who (or whose organization) is part of a clinical trial such that entry of data initiates transfer of data to the conversion from FHIR to OMOP.  

Discussion of OMOP-Atlas to FHIR-CQL conversion

The use case this dQM/OMOP group has designed is the reverse of the FHIR-OMOP Oncology group design, basically requesting all patients who meet criteria for a phenotype defined in Atlas with OMOP and SQL. In the dQM-OMOP workflow, the patients are not known and the retrieve request is to provide all patients meeting criteria for the cohort.

Thomas White (MedStar) presented another use case similar to the "gaps in care" approach addressed in Data Exchange for Quality Measures (DEQM), except that all patients meeting the cohort are known in an OMOP data set. The use case uses bulk query to obtain all new data for specific resources for just that patient set (known Atlas-based cohorts) and subsequently uses the retrieved data to determine which patients the existing dataset have gaps in care that can be addressed. Currently FHIR bulk query is not available in all EHRs, it is required by the end of 2022.  He noted that the existing dQDM-OMOP use case (I.e., provide all patients meeting a cohort definition) is still critically important; the gaps-in-care use case in an additional requirement for OMOP to FHIR efforts.

Paul Denning provided a link to the FHIR Quality Measure IG (the build version to be published very soon: http://build.fhir.org/ig/HL7/cqf-measures/capabilities.html. The directory for published versions is located at http://hl7.org/fhir/us/cqfmeasures/history.html (this new publication should be version 4.1.0).


Discussion about potential synthetic patient set in (a) FHIR, (b) OMOP

Not discussed due to lack of time.
Follow up next steps from last call (March 9) - validate actions needed: Reminder from last call regarding COVID Criteria for cohort: https://github.com/National-COVID-Cohort-Collaborative/Phenotype_Data_Acquisition/wiki/Latest-Phenotype; Describe requirements for the various components of the architecture - Seeking input from WG members:No new information about potential participants. The use case remains a valid and useful one based on today's discussion. Will need to add an additional use case to identify gaps-in-care for a known OMOP patient data set, potentially using bulk data requests.

Terminology:

  • Infrastructure:
    • VSAC value sets and FHIR API
    • Programmatic methodology for extracting VSAC value sets and mapping terms to OMOP terminology (current manual upload)
    • Recommendations for handling concepts missing from OMOP (such as examples Qi experienced for HSLOC and CDC Race and Ethnicity Codes)
    • Subscription or periodic requery when VSAC updates the terminology
  • Participants:
    • TBD
TBD

Expression:

  • Infrastructure:
    • Atlas - SQL capability exists - need Atlas SQL instance for pilot testing
    • FHIR - CQL capability exists - need FHIR CQL instance for pilot testing
    • Expression conversion (what infrastructure is required here):
      • Atlas phenotype to FHIR cohort conversion
      • FHIR cohort expression with CQL to Atlas phenotype conversion
  • Participants:
    • TBD
TBD

Data Query and Response:

  • Infrastructure:
    • Atlas data store for synthetic patients
    • FHIR data store for synthetic patients
    • Query capability for Atlas patients and retrieve of OMOP cohort(s)
    • Query capability for FHIR patients and retrieve of FHIR synthetic cohort(s)
    • Structure to compare OMOP cohort with FHIR cohort, identify concordance and challenges
  • Participants:
    • TBD
TBD

Next Steps from March 9:

  • Continue to build on Project Scope Statement PSS-1981 such that it can be progressed.
  • Further discussions with Vulcan to understand potential Accelerator support.
  • At this point, if folks want to move forward with the project and/or Connectathon piloting, we definitely need people to step up to do the work to define the elements, to create the prototypes, and to pilot them.

New Next Steps:

Group members will review capabilities discussed regarding automated mapping of VSAC (or other) value sets to OMOP.

Add known OMOP cohort gaps-in-care request as a new OMOP to FHIR use case in addition to the one to identify members of a cohort/phenotype. New Graphic to describe the 2 dQM-OMOP use cases:

Continue to generate support for activities. It is unlikely that a May FHIR Connectathon for the OMOP to FHIR use case(s) will be possible but perhaps work can occur in the NCQA/FHIR Digital Quality Summit.

AdjournmentAdjourned at 11:02 AM EDT


Attendees


AttendeeAttendee's OrganizationAttendee's emailPresent
1Abdullah RafiqiESAC

abdullah.rafiqi@esacinc.com

yes
2Andrew Frangleton ClinicalArchitecture
yes
3NCQA

4

Ben Hamlin

NCQA

hamlin@ncqa.org


5Bryan Laraway 


6Alphora
yes
7


8Johns Hopkinsdgabrie4@jh.eduyes
9Dipti Gandhi


10Dorothy LeeNCQA

11Edward Smith


12Evan Patrick Minty


13

Floyd Eisenberg

iParsimony, LLC

FEisenberg@iParsimony.com

yes
14ESAC

15Jack BrewsterIQVIA
yes
16James Brash 


17Jamie Smith


18


19John David Evans


20JP

yes
21Julia Dawson

yes
22


23Justin McKelvy


24Kristin Kostka

yes
25Latasha Estrada


26Luis Alaniz 


27


28NCQA

29Ming Dunajick


30


31

yes
32


33

yes
34


35

yes
36Raju Hemadri


37


38@Sandra Siami


39Sebastian van SandijkOdysseus
yes
40Shaun Shakib

yes
41

Telligen

SRankins@telligen.com


42MedStar Health
yes
43Vickie Reyes (GC) 

yes
44

yes
45Zhen Lin

yes
46JD LiddilM2GENjames.liddil@m2gen.com
  • No labels